Please assess the completion status of the following clinical trial:

Trial Title: New Biomarkers for Invasive Fungal Infections in Paediatric Haemato-oncology

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Any febrile episode in :~   * either a neutropenic child suffering from acute lymphoblastic leukemia under induction chemotherapy or relapse, acute myeloblastic leukemia under chemotherapy (all cycles of chemotherapy included) or myelodysplasic syndrome~  * an allogenetic hematopoietic stem cell transplantation recipient child, from conditioning till 3 months or receiving aggressive immunosuppressive therapy for at least 1 months~2. Age of children will be from 3 months till 18 years~3. Informed consent from the parents and from children older than 12 years obtained~Exclusion Criteria:~1. Any previous history of fungal infection (proven, probable or possible) with prescription of secondary oral prophylaxis (voriconazole or posaconazole) under current use at the time of the study.~2. Any previous episode already enrolled (only one episode/patient).

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: OTHER): single cohort of patient

Based on this trial design, predict the completion outcome and termination type (if applicable).